US Congress House Bill 934 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on February 7 2017 - 25% progression, died in committee
Action: 2017-02-10 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Personal Drug Importation Fairness Act of 2017 This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.

Personal Drug Importation Fairness Act of 2017

Rep. Keith Ellison [D-MN]

Rep. Dana Rohrabacher [R-CA]

Date	Chamber	Action
2017-02-10	House	Referred to the Subcommittee on Health.
2017-02-07	House	Referred to the House Committee on Energy and Commerce.
2017-02-07	House	Introduced in House

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/house-bill/934/all-info
Text	https://www.congress.gov/115/bills/hr934/BILLS-115hr934ih.pdf